Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

6,677 evidence items · page 169 / 268

0 mol/LFolic acid and folinic acid inhibit the growth of Plasmodium falciparum in vitro at concentrations greater than 10^(-4.5) mol/L and 10^(-3.5) mol/L, respectively.

Kenyapaludismepublished 1999The American journal of tropical medicine and hygieneeurope_pmcdocument of 3 observationsDOI 10.4269/ajtmh.1999.60.943

20 %HPV type 52 was detected in 20% of 326 hrHPV-positive samples among HIV-positive women with CIN2+ in Nairobi, Kenya.

KenyaHPV type 52published 2021JAMA oncologyPubMeddocument of 16 observations

49.6 %Nearly half of the women who tested HPV positive (n = 1540; 49.6%) were eligible for rescreening using VIA.

Kenyainfection à HPVpublished 2026BMC cancerPubMeddocument of 12 observations

35 %In the comparison site, 35% of caregivers sought care for pneumonia on the same day of symptom onset.

Kenyapneumoniepublished 2025Frontiers in public healthPubMeddocument of 12 observations

78 %Using a population-derived denominator for age-eligible children, malaria vaccine coverage was 78% for dose 1 of RTS,S/AS01 in Kenya's pilot implementation.

Kenyapaludismeobserved 2019-2022published 2023Malaria journaleurope_pmcdocument of 10 observations

70 per_100Antibody prevalence in adults was high at all time points (> 70%) for apical membrane antigen 1, erythrocyte-binding antigen 175, erythrocyte-binding protein-2, glutamate rich protein (GLURP)-R2, merozoite surface protein (MSP) 1 (19), MSP-1 (42), and liver-stage antigen-1.

Kenyapaludismepublished 2020The American journal of tropical medicine and hygienePubMeddocument of 3 observations

31.7 %Diagnostic information based on guidelines was complete for 1030 (31.7%) of a total of 3246 patients included.

Kenyacancer (non précisé)published 2025Journal of the National Cancer Instituteeurope_pmcdocument of 9 observations

0.51 aorThe odds of never being HBV infected were lower among older individuals aged 25–29 years (adjusted odds ratio 0.51).

Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations

6,628 patientsThe number of patients recorded at medical registers with diabetes in public hospitals in Murang'a County was 6628, representing 0.45%.

Kenyadiabète (non précisé)published 2022The Pan African medical journalPubMeddocument of 2 observations

14.3 %Of 1,200 registered cancer cases, 171 cases (14.3%) met clinical strength-of-evidence criteria for association with HIV infection/AIDS.

Kenyacancer (non précisé) · VIH/sidaobserved August 1 to October 31, 2011published 2014PloS oneeurope_pmcdocument of 4 observations

73.5 %Among 3891 PLHIV with documented IPT treatment outcomes in Kenya between July 2015 and June 2018, follow-up for active tuberculosis at 6-month post-IPT completion was done for 2729 (73.5%).

Kenyatuberculose · VIH/sidaobserved July 2015 to June 2018published 2020PloS onePubMeddocument of 8 observations

11.7 %11.7% of respondents reported having cardiovascular disease.

Kenyamaladies cardiovasculairesobserved 2018published 2021PloS onePubMeddocument of 7 observations

15.4 %Among the 435 participants, 15.4% reported having type 2 diabetes.

Kenyadiabète de type 2observed 2019published 2024BMC health services researchPubMeddocument of 7 observations

2 casesTwo women met the definition for incident syphilis.

Kenyasyphilispublished 2022The American journal of tropical medicine and hygienePubMeddocument of 8 observations

6.8 %Prevalence at first nasal swab of SARS-CoV-2 was 6.8% among participants in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observed 19 July 2022 to 1 March 2024published 2025BMC infectious diseasesPubMeddocument of 8 observations

52.2 %In 2019, 52.2% of Kenya's population resided in areas with very low Plasmodium falciparum parasite prevalence (<1%).

Kenyapaludismeobserved 2019published 2021PLOS global public healtheurope_pmcdocument of 11 observations

93.7 %Dominant IRNI haplotype occurred in 93.7% of samples.

Kenyapaludismeobserved September 2020–September 2022, extended to January 2024 for Mfangano Islandpublished 2026Scientific reportsPubMeddocument of 11 observations

18 US$The mean total unit cost of HIV testing services (HTS) was US$18 in Kenya.

KenyaVIH/sidaobserved 2019published 2023BMC health services researchPubMeddocument of 11 observations

48 childrenA cohort of 48 Gambian children was protected against malaria by fortnightly administration of Maloprim (pyrimethamine and dapsone) for 2 years between their 3 and 5 birthdays.

Kenyapaludismepublished 1988Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 3 observationsDOI 10.1016/0035-9203(88)90263-5

0.1 %Only 0.1% of AFRICOS participants reported men who have sex with men (MSM) as a risk factor.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 13 observations

87 %Among people with HIV reporting hazardous alcohol use, the intervention arm had viral suppression of 87% compared with 72% in the control arm.

KenyaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

Less than 1% of all malaria infections were among children aged less than 1 year in the seasonal low transmission zone.

Kenyapaludismepublished 2016Malaria journaleurope_pmcdocument of 12 observations

17.6 %Among 336 blood samples collected from hospital patients in Busia, Bungoma, and Kakamega counties between January 2018 and February 2019, 17.6% (59/336) were positive for Plasmodium falciparum.

Kenyapaludismeobserved January 2018 to February 2019published 2022Malaria journalPubMeddocument of 5 observations

93.8 %Of the surveyed facilities in Kenya, 93.8% offered chronic respiratory disease diagnosis and/or management services.

Kenyachronic respiratory diseaseobserved 2019–2020published 2022BMC health services researchPubMeddocument of 8 observations

8 %The human-biting density of Anopheles gambiae sensu lato was consistently higher in the intervention zone compared to the control zone, but showed 8% reduction compared to pre-intervention biting rates—versus 94% increase in the control zone.

Kenyapaludismeobserved May 1994 to April 1995published 1996Medical and veterinary entomologyeurope_pmcdocument of 5 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.